GB202103578D0 - Prevention and treatment of infections including those caused by coronavirus - Google Patents

Prevention and treatment of infections including those caused by coronavirus

Info

Publication number
GB202103578D0
GB202103578D0 GBGB2103578.7A GB202103578A GB202103578D0 GB 202103578 D0 GB202103578 D0 GB 202103578D0 GB 202103578 A GB202103578 A GB 202103578A GB 202103578 D0 GB202103578 D0 GB 202103578D0
Authority
GB
United Kingdom
Prior art keywords
coronavirus
prevention
treatment
including those
those caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB2103578.7A
Other versions
GB2607262A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immodulon Therapeutics Ltd
Original Assignee
Immodulon Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immodulon Therapeutics Ltd filed Critical Immodulon Therapeutics Ltd
Priority to GB2103578.7A priority Critical patent/GB2607262A/en
Publication of GB202103578D0 publication Critical patent/GB202103578D0/en
Publication of GB2607262A publication Critical patent/GB2607262A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB2103578.7A 2021-03-15 2021-03-15 Prevention and treatment of infections including those caused by coronavirus Withdrawn GB2607262A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2103578.7A GB2607262A (en) 2021-03-15 2021-03-15 Prevention and treatment of infections including those caused by coronavirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2103578.7A GB2607262A (en) 2021-03-15 2021-03-15 Prevention and treatment of infections including those caused by coronavirus

Publications (2)

Publication Number Publication Date
GB202103578D0 true GB202103578D0 (en) 2021-04-28
GB2607262A GB2607262A (en) 2022-12-07

Family

ID=75623171

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2103578.7A Withdrawn GB2607262A (en) 2021-03-15 2021-03-15 Prevention and treatment of infections including those caused by coronavirus

Country Status (1)

Country Link
GB (1) GB2607262A (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202004007D0 (en) * 2020-03-19 2020-05-06 Immodulon Therapeutics Ltd Coronavirus
CN111265500B (en) * 2020-03-02 2022-02-01 广西医科大学第一附属医院 Pharmaceutical composition for preventing and treating COVID-19 and preparation method thereof

Also Published As

Publication number Publication date
GB2607262A (en) 2022-12-07

Similar Documents

Publication Publication Date Title
EP3980400A4 (en) Peptidomimetics for the treatment of coronavirus and picornavirus infections
GB202005097D0 (en) Treatment and/or prevention of covid-19 infection
EP4106752A4 (en) Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors
EP4119156A4 (en) Medicament for treatment and/or prevention of cancer
ZA202208630B (en) Use of pharmaceutical composition for preventing and treating novel coronavirus pneumonia
EP4132967A4 (en) Methods to prevent sars-cov-2 infection and treat covid-19
IL277315B (en) Methods and composition for treating coronavirus infection
EP4058037A4 (en) Fibroblast-based therapy for treatment and prevention of stroke
GB202013874D0 (en) Treatment and prevention of viral infections
SG11202008791UA (en) Agent for prevention and/or treatment of pseudomonas aeruginosa infection
EP4110369A4 (en) Methods of treatment and related compositions
ZA202210585B (en) Parapoxvirus for conditioning for and treatment of coronavirus infections
GB202103578D0 (en) Prevention and treatment of infections including those caused by coronavirus
EP4153609A4 (en) Compositions and methods for prevention of coronavirus infection
GB2595513B (en) Treatment of infections
EP4121038A4 (en) Compositions and methods for the treatment of coronavirus infection and respiratory compromise
EP4132503A4 (en) Methods for treatment of coronavirus infections
IL307872A (en) Novel compositions and methods for treating coronavirus infections
EP4121099A4 (en) Methods of treating viral infections and health consequences
EP4119158A4 (en) Medicament for treatment and/or prevention of cancer
EP4119157A4 (en) Medicament for treatment and/or prevention of cancer
EP4119160A4 (en) Medicament for treatment and/or prevention of cancer
EP4119159A4 (en) Medicament for treatment and/or prevention of cancer
GB201908544D0 (en) Treatment and prevention of disease mediated by wwp2
IL276627A (en) Compositions for diagnosis and treatment of coronavirus infections

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)